Immunity Character of Dendritic Cells Derived from Two Blood

LI Qi-ling,BU Ning,LI Ya-ling,YU Yue-cheng,FANG Jing,XIN Xiao-yan
DOI: https://doi.org/10.3969/j.issn.1672-4992.2006.07.004
2006-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate how to induce dendritic cells(DC) from umbilical cord blood(UCB) and peripheral blood(PB) and test it’s immunological characteristics. Methods: Ten UCB and 10 normal adult PB were collected. The mononuclear cells (MNCs) of two groups(UCB group and PB group) were separated and cultured with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-4(IL-4) and tumor necrosis factor-α(TNF-α) for 12 days. The cell configuration was observed by optical microscope every day. CD11c,CD80,CD86 and HLA-DR were tested by flow cytometry at 3d, 6d, and 10d separately. The cell configuration was observed by transmission electric microscope and scan electric microscope at 10d. The DCs were cultured with lymphocyte for testing the ability to stimulate lymphocyte proliferation at 12d. Results: DCs with typical morphological characteristics were induced successfully in two groups. The yields of DCs from UCB group were higher than that from PB group(P0.01). DCs in two groups were not different in stimulating lymphocyte proliferation(P0.05). Conclusion: The MNs in UCB and PB may be induced into mature DC. The yields of DCs from UCB are higher than that from PB. DCs from the two sources have same ability in stimulating lymphocyte proliferation. Therefore, UCB may be valuable origin for DC immunotherapy.
What problem does this paper attempt to address?